Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 30 entries
Sorted by: Best Match Show Resources per page
Broadening diversity in the geosciences through teacher–student workshops that emphasize community-based research projects

Broadening Participation in Engineering AND Program Evaluation

Luera G, Napieralski J.
GSID: sKdIA1hbWrYJ
KS Murray, J Napieralski, G Luera… - Journal of …, 2012 - Taylor & Francis

ABSTRACT The Geosciences Institute for Research and Education at the University of Michigan–Dearborn has been an example of a successful and effective model in increasing the participation of underrepresented groups in the geosciences. The program emphasizes involving middle school...

Cite
Murray, K. S., Napieralski, J., Luera, G., Thomas-Brown, K., & Reynolds-Keefer, L. (2012). Broadening diversity in the geosciences through teacher–student workshops that emphasize community-based research projects. Journal of Geoscience Education, 60(2), 179-188.
Murray, Kent S., et al. "Broadening diversity in the geosciences through teacher–student workshops that emphasize community-based research projects." Journal of Geoscience Education 60.2 (2012): 179-188.
Copy Download .nbib Format: MLA
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysł-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU.
PMID: 34774650
Radiother Oncol. 2021 Nov 11;166:1-7. doi: 10.1016/j.radonc.2021.11.005. Epub 2021 Nov 11.

BACKGROUND AND PURPOSE: The Phoenix definition for biochemical failure (BCF) after radiotherapy uses nadir PSA (nPSA) + 2 ng/mL to classify a BCF and was derived from conventionally fractionated radiotherapy, which produces significantly higher nPSAs than stereotactic body radiotherapy...

Cite
Ma TM, Roy S, Wu X, et al. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiother Oncol. 2021;166:1-7doi: 10.1016/j.radonc.2021.11.005.
Ma, T. M., Roy, S., Wu, X., Mantz, C., Fuller, D., Miszczyk, L., Napieralska, A., Namysł-Kaletka, A., Bagshaw, H. P., Buyyounouski, M. K., Glicksman, R., Loblaw, D. A., Katz, A., Upadhyaya, S. K., Nickols, N., Steinberg, M. L., Philipson, R., Aghdam, N., Suy, S., Pepin, A., Collins, S. P., Boutros, P., Rettig, M. B., Calais, J., Wang, M., Zaorsky, N., & Kishan, A. U. (2021). Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1661-7. https://doi.org/10.1016/j.radonc.2021.11.005
Ma, Ting Martin, et al. "Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 1-7. doi: https://doi.org/10.1016/j.radonc.2021.11.005
Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysł-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiother Oncol. 2021 Nov 11;166:1-7. doi: 10.1016/j.radonc.2021.11.005. Epub 2021 Nov 11. PMID: 34774650.
Copy Download .nbib Format: NLM
Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials.

Diagnostics (Basel, Switzerland)

Napieralska A, Mizia-Malarz A, Stolpa W, Pawłowska E, Krawczyk MA, Konat-Bąska K, Kaczorowska A, Brąszewski A, Harat M.
PMID: 34943596
Diagnostics (Basel). 2021 Dec 14;11(12). doi: 10.3390/diagnostics11122360.

We performed a multi-institutional analysis of 74 children with ependymoma to evaluate to what extent the clinical outcome of prospective trials could be reproduced in routine practice. The evaluation of factors that correlated with outcome was performed with a...

Cite
Napieralska A, Mizia-Malarz A, Stolpa W, et al. Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials. Diagnostics (Basel). 2021;11(12)doi: 10.3390/diagnostics11122360.
Napieralska, A., Mizia-Malarz, A., Stolpa, W., Pawłowska, E., Krawczyk, M. A., Konat-Bąska, K., Kaczorowska, A., Brąszewski, A., & Harat, M. (2021). Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials. Diagnostics (Basel, Switzerland), 11(12), . https://doi.org/10.3390/diagnostics11122360
Napieralska, Aleksandra, et al. "Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials." Diagnostics (Basel, Switzerland) vol. 11,12 (2021). doi: https://doi.org/10.3390/diagnostics11122360
Napieralska A, Mizia-Malarz A, Stolpa W, Pawłowska E, Krawczyk MA, Konat-Bąska K, Kaczorowska A, Brąszewski A, Harat M. Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials. Diagnostics (Basel). 2021 Dec 14;11(12). doi: 10.3390/diagnostics11122360. PMID: 34943596.
Copy Download .nbib Format: NLM
Microbial chemolithotrophy mediates oxidative weathering of granitic bedrock.

Proceedings of the National Academy of Sciences of the United States of America

Napieralski SA, Buss HL, Brantley SL, Lee S, Xu H, Roden EE.
PMID: 31843926
Proc Natl Acad Sci U S A. 2019 Dec 16; doi: 10.1073/pnas.1909970117. Epub 2019 Dec 16.

The flux of solutes from the chemical weathering of the continental crust supplies a steady supply of essential nutrients necessary for the maintenance of Earth's biosphere. Promotion of weathering by microorganisms is a well-documented phenomenon and is most often...

Cite
Napieralski SA, Buss HL, Brantley SL, et al. Microbial chemolithotrophy mediates oxidative weathering of granitic bedrock. Proc Natl Acad Sci U S A. 2019;doi: 10.1073/pnas.1909970117.
Napieralski, S. A., Buss, H. L., Brantley, S. L., Lee, S., Xu, H., & Roden, E. E. (2019). Microbial chemolithotrophy mediates oxidative weathering of granitic bedrock. Proceedings of the National Academy of Sciences of the United States of America, . https://doi.org/10.1073/pnas.1909970117
Napieralski, Stephanie A, et al. "Microbial chemolithotrophy mediates oxidative weathering of granitic bedrock." Proceedings of the National Academy of Sciences of the United States of America vol. (2019). doi: https://doi.org/10.1073/pnas.1909970117
Napieralski SA, Buss HL, Brantley SL, Lee S, Xu H, Roden EE. Microbial chemolithotrophy mediates oxidative weathering of granitic bedrock. Proc Natl Acad Sci U S A. 2019 Dec 16; doi: 10.1073/pnas.1909970117. Epub 2019 Dec 16. PMID: 31843926; PMCID: PMC6936594.
Copy Download .nbib Format: NLM
Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials.

Diagnostics (Basel, Switzerland)

Napieralska A, Mizia-Malarz A, Stolpa W, Pawłowska E, Krawczyk MA, Konat-Bąska K, Kaczorowska A, Brąszewski A, Harat M.
PMID: 34943596
Diagnostics (Basel). 2021 Dec 14;11(12). doi: 10.3390/diagnostics11122360.

We performed a multi-institutional analysis of 74 children with ependymoma to evaluate to what extent the clinical outcome of prospective trials could be reproduced in routine practice. The evaluation of factors that correlated with outcome was performed with a...

Cite
Napieralska A, Mizia-Malarz A, Stolpa W, et al. Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials. Diagnostics (Basel). 2021;11(12)doi: 10.3390/diagnostics11122360.
Napieralska, A., Mizia-Malarz, A., Stolpa, W., Pawłowska, E., Krawczyk, M. A., Konat-Bąska, K., Kaczorowska, A., Brąszewski, A., & Harat, M. (2021). Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials. Diagnostics (Basel, Switzerland), 11(12), . https://doi.org/10.3390/diagnostics11122360
Napieralska, Aleksandra, et al. "Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials." Diagnostics (Basel, Switzerland) vol. 11,12 (2021). doi: https://doi.org/10.3390/diagnostics11122360
Napieralska A, Mizia-Malarz A, Stolpa W, Pawłowska E, Krawczyk MA, Konat-Bąska K, Kaczorowska A, Brąszewski A, Harat M. Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials. Diagnostics (Basel). 2021 Dec 14;11(12). doi: 10.3390/diagnostics11122360. PMID: 34943596; PMCID: PMC8700631.
Copy Download .nbib Format: NLM
PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients.

Breast care (Basel, Switzerland)

Napieralski R, Schricker G, Auer G, Aubele M, Perkins J, Magdolen V, Ulm K, Hamann M, Walch A, Weichert W, Kiechle M, Wilhelm OG.
PMID: 34720812
Breast Care (Basel). 2021 Oct;16(5):523-531. doi: 10.1159/000510468. Epub 2020 Dec 17.

BACKGROUND: PITX2 DNA methylation has been shown to predict outcomes in high-risk breast cancer patients after anthracycline-based chemotherapy. To determine its prognostic versus predictive value, the impact of PITX2 DNA methylation on outcomes was studied in an untreated cohort...

Cite
Napieralski R, Schricker G, Auer G, et al. PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients. Breast Care (Basel). 2020;16(5):523-531doi: 10.1159/000510468.
Napieralski, R., Schricker, G., Auer, G., Aubele, M., Perkins, J., Magdolen, V., Ulm, K., Hamann, M., Walch, A., Weichert, W., Kiechle, M., & Wilhelm, O. G. (2021). PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients. Breast care (Basel, Switzerland), 16(5), 523-531. https://doi.org/10.1159/000510468
Napieralski, Rudolf, et al. "PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients." Breast care (Basel, Switzerland) vol. 16,5 (2021): 523-531. doi: https://doi.org/10.1159/000510468
Napieralski R, Schricker G, Auer G, Aubele M, Perkins J, Magdolen V, Ulm K, Hamann M, Walch A, Weichert W, Kiechle M, Wilhelm OG. PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients. Breast Care (Basel). 2021 Oct;16(5):523-531. doi: 10.1159/000510468. Epub 2020 Dec 17. PMID: 34720812; PMCID: PMC8543364.
Copy Download .nbib Format: NLM
Tracheal cancer - treatment results, prognostic factors and incidence of other neoplasms.

Radiology and oncology

Napieralska A, Miszczyk L, Blamek S.
PMID: 27904449
Radiol Oncol. 2016 Sep 08;50(4):409-417. doi: 10.1515/raon-2016-0046. eCollection 2016 Dec 01.

BACKGROUND: Tracheal cancers (TC) are rare and treatment results that are reported are typically not satisfactory. The purpose of this research was assessment of the results of treatment of TC patients, identification of potential additional surgery candidates, evaluation of...

Cite
Napieralska A, Miszczyk L, Blamek S. Tracheal cancer - treatment results, prognostic factors and incidence of other neoplasms. Radiol Oncol. 2016;50(4):409-417doi: 10.1515/raon-2016-0046.
Napieralska, A., Miszczyk, L., & Blamek, S. (2016). Tracheal cancer - treatment results, prognostic factors and incidence of other neoplasms. Radiology and oncology, 50(4), 409-417. https://doi.org/10.1515/raon-2016-0046
Napieralska, Aleksandra, et al. "Tracheal cancer - treatment results, prognostic factors and incidence of other neoplasms." Radiology and oncology vol. 50,4 (2016): 409-417. doi: https://doi.org/10.1515/raon-2016-0046
Napieralska A, Miszczyk L, Blamek S. Tracheal cancer - treatment results, prognostic factors and incidence of other neoplasms. Radiol Oncol. 2016 Sep 08;50(4):409-417. doi: 10.1515/raon-2016-0046. eCollection 2016 Dec 01. PMID: 27904449; PMCID: PMC5120581.
Copy Download .nbib Format: NLM
No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.

Multiple sclerosis journal - experimental, translational and clinical

Havrdová E, Arnold DL, Bar-Or A, Comi G, Hartung HP, Kappos L, Lublin F, Selmaj K, Traboulsee A, Belachew S, Bennett I, Buffels R, Garren H, Han J, Julian L, Napieralski J, Hauser SL, Giovannoni G.
PMID: 29568544
Mult Scler J Exp Transl Clin. 2018 Mar 12;4(1):2055217318760642. doi: 10.1177/2055217318760642. eCollection 2018.

BACKGROUND: No evidence of disease activity (NEDA; defined as no 12-week confirmed disability progression, no protocol-defined relapses, no new/enlarging T2 lesions and no T1 gadolinium-enhancing lesions) using a fixed-study entry baseline is commonly used as a treatment outcome in...

Cite
Havrdová E, Arnold DL, Bar-Or A, et al. No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a. Mult Scler J Exp Transl Clin. 2018;4(1):2055217318760642doi: 10.1177/2055217318760642.
Havrdová, E., Arnold, D. L., Bar-Or, A., Comi, G., Hartung, H. P., Kappos, L., Lublin, F., Selmaj, K., Traboulsee, A., Belachew, S., Bennett, I., Buffels, R., Garren, H., Han, J., Julian, L., Napieralski, J., Hauser, S. L., & Giovannoni, G. (2018). No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a. Multiple sclerosis journal - experimental, translational and clinical, 4(1), 2055217318760642. https://doi.org/10.1177/2055217318760642
Havrdová, Eva, et al. "No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a." Multiple sclerosis journal - experimental, translational and clinical vol. 4,1 (2018): 2055217318760642. doi: https://doi.org/10.1177/2055217318760642
Havrdová E, Arnold DL, Bar-Or A, Comi G, Hartung HP, Kappos L, Lublin F, Selmaj K, Traboulsee A, Belachew S, Bennett I, Buffels R, Garren H, Han J, Julian L, Napieralski J, Hauser SL, Giovannoni G. No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a. Mult Scler J Exp Transl Clin. 2018 Mar 12;4(1):2055217318760642. doi: 10.1177/2055217318760642. eCollection 2018. PMID: 29568544; PMCID: PMC5858626.
Copy Download .nbib Format: NLM
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysł-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU.
PMID: 34774650
Radiother Oncol. 2021 Nov 11;166:1-7. doi: 10.1016/j.radonc.2021.11.005. Epub 2021 Nov 11.

BACKGROUND AND PURPOSE: The Phoenix definition for biochemical failure (BCF) after radiotherapy uses nadir PSA (nPSA) + 2 ng/mL to classify a BCF and was derived from conventionally fractionated radiotherapy, which produces significantly higher nPSAs than stereotactic body radiotherapy...

Cite
Ma TM, Roy S, Wu X, et al. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiother Oncol. 2021;166:1-7doi: 10.1016/j.radonc.2021.11.005.
Ma, T. M., Roy, S., Wu, X., Mantz, C., Fuller, D., Miszczyk, L., Napieralska, A., Namysł-Kaletka, A., Bagshaw, H. P., Buyyounouski, M. K., Glicksman, R., Loblaw, D. A., Katz, A., Upadhyaya, S. K., Nickols, N., Steinberg, M. L., Philipson, R., Aghdam, N., Suy, S., Pepin, A., Collins, S. P., Boutros, P., Rettig, M. B., Calais, J., Wang, M., Zaorsky, N., & Kishan, A. U. (2021). Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1661-7. https://doi.org/10.1016/j.radonc.2021.11.005
Ma, Ting Martin, et al. "Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 1-7. doi: https://doi.org/10.1016/j.radonc.2021.11.005
Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysł-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiother Oncol. 2021 Nov 11;166:1-7. doi: 10.1016/j.radonc.2021.11.005. Epub 2021 Nov 11. PMID: 34774650.
Copy Download .nbib Format: NLM
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysł-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU.
PMID: 34774650
Radiother Oncol. 2021 Nov 11;166:1-7. doi: 10.1016/j.radonc.2021.11.005. Epub 2021 Nov 11.

BACKGROUND AND PURPOSE: The Phoenix definition for biochemical failure (BCF) after radiotherapy uses nadir PSA (nPSA) + 2 ng/mL to classify a BCF and was derived from conventionally fractionated radiotherapy, which produces significantly higher nPSAs than stereotactic body radiotherapy...

Cite
Ma TM, Roy S, Wu X, et al. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiother Oncol. 2021;166:1-7doi: 10.1016/j.radonc.2021.11.005.
Ma, T. M., Roy, S., Wu, X., Mantz, C., Fuller, D., Miszczyk, L., Napieralska, A., Namysł-Kaletka, A., Bagshaw, H. P., Buyyounouski, M. K., Glicksman, R., Loblaw, D. A., Katz, A., Upadhyaya, S. K., Nickols, N., Steinberg, M. L., Philipson, R., Aghdam, N., Suy, S., Pepin, A., Collins, S. P., Boutros, P., Rettig, M. B., Calais, J., Wang, M., Zaorsky, N., & Kishan, A. U. (2021). Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1661-7. https://doi.org/10.1016/j.radonc.2021.11.005
Ma, Ting Martin, et al. "Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 1-7. doi: https://doi.org/10.1016/j.radonc.2021.11.005
Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysł-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiother Oncol. 2021 Nov 11;166:1-7. doi: 10.1016/j.radonc.2021.11.005. Epub 2021 Nov 11. PMID: 34774650.
Copy Download .nbib Format: NLM
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysł-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU.
PMID: 34774650
Radiother Oncol. 2021 Nov 11;166:1-7. doi: 10.1016/j.radonc.2021.11.005. Epub 2021 Nov 11.

BACKGROUND AND PURPOSE: The Phoenix definition for biochemical failure (BCF) after radiotherapy uses nadir PSA (nPSA) + 2 ng/mL to classify a BCF and was derived from conventionally fractionated radiotherapy, which produces significantly higher nPSAs than stereotactic body radiotherapy...

Cite
Ma TM, Roy S, Wu X, et al. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiother Oncol. 2021;166:1-7doi: 10.1016/j.radonc.2021.11.005.
Ma, T. M., Roy, S., Wu, X., Mantz, C., Fuller, D., Miszczyk, L., Napieralska, A., Namysł-Kaletka, A., Bagshaw, H. P., Buyyounouski, M. K., Glicksman, R., Loblaw, D. A., Katz, A., Upadhyaya, S. K., Nickols, N., Steinberg, M. L., Philipson, R., Aghdam, N., Suy, S., Pepin, A., Collins, S. P., Boutros, P., Rettig, M. B., Calais, J., Wang, M., Zaorsky, N., & Kishan, A. U. (2021). Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1661-7. https://doi.org/10.1016/j.radonc.2021.11.005
Ma, Ting Martin, et al. "Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 1-7. doi: https://doi.org/10.1016/j.radonc.2021.11.005
Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysł-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiother Oncol. 2021 Nov 11;166:1-7. doi: 10.1016/j.radonc.2021.11.005. Epub 2021 Nov 11. PMID: 34774650.
Copy Download .nbib Format: NLM
High-Grade Gliomas in Children-A Multi-Institutional Polish Study.

Cancers

Napieralska A, Krzywon A, Mizia-Malarz A, Sosna-Zielińska J, Pawłowska E, Krawczyk MA, Konat-Bąska K, Kaczorowska A, Dąbrowska A, Harat M.
PMID: 33923337
Cancers (Basel). 2021 Apr 24;13(9). doi: 10.3390/cancers13092062.

Due to the rarity of high-grade gliomas (HGG) in children, data on this topic are scarce. The study aimed to investigate the long-term results of treatment of children with HGG and to identify factors related to better survival. We...

Cite
Napieralska A, Krzywon A, Mizia-Malarz A, et al. High-Grade Gliomas in Children-A Multi-Institutional Polish Study. Cancers (Basel). 2021;13(9)doi: 10.3390/cancers13092062.
Napieralska, A., Krzywon, A., Mizia-Malarz, A., Sosna-Zielińska, J., Pawłowska, E., Krawczyk, M. A., Konat-Bąska, K., Kaczorowska, A., Dąbrowska, A., & Harat, M. (2021). High-Grade Gliomas in Children-A Multi-Institutional Polish Study. Cancers, 13(9), . https://doi.org/10.3390/cancers13092062
Napieralska, Aleksandra, et al. "High-Grade Gliomas in Children-A Multi-Institutional Polish Study." Cancers vol. 13,9 (2021). doi: https://doi.org/10.3390/cancers13092062
Napieralska A, Krzywon A, Mizia-Malarz A, Sosna-Zielińska J, Pawłowska E, Krawczyk MA, Konat-Bąska K, Kaczorowska A, Dąbrowska A, Harat M. High-Grade Gliomas in Children-A Multi-Institutional Polish Study. Cancers (Basel). 2021 Apr 24;13(9). doi: 10.3390/cancers13092062. PMID: 33923337; PMCID: PMC8123180.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 30 entries